HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.

Abstract
8-Chloro-adenosine (8-Cl-Ado) is an adenosine derivative, which inhibits proliferation and induces apoptosis in various tumor cells. Subtoxic concentration of 8-Cl-Ado sensitizes human hepatoma cells to tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-triggered apoptosis. However, the molecular mechanism by which TRAIL cytotoxicity is amplified by 8-Cl-Ado is unknown. In the present study, we demonstrated by Western blot and real-time PCR that 8-Cl-Ado selectively up-regulated death receptor 5 (DR5), but not death receptor 4 (DR4), at both protein and RNA levels in human hepatoma cell line BEL-7402. Analysis of the transcriptional regulation of DR5 expression by using Dual-Luciferase reporter assay system demonstrated that the 5'-flanking fragment -207 to -145 upstream to the ATG site within the DR5 promoter region was responsible for the 8-Cl-Ado-upregulated DR5 expression. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) confirmed that 8-Cl-Ado treatment facilitated transcription factor Sp1 binding to its cis-element -198/-189 in the DR5 promoter, suggesting that Sp1 is at least one of the 8-Cl-Ado-responsive transcription factors. However, we observed that nuclear factor kappaB (NF-kappaB) activity remained invariable in the cells treated with 8-Cl-Ado. These data allowed us to draw a conclusion that 8-Cl-Ado-enhanced DR5 expression is regulated by Sp1 binding to the -198/-189 cis-element in DR5 promoter without affecting NF-kappaB activity in the hepatoma cells. This study may shed light on further screening the regulators of DR5 expression and developing novel therapeutic drugs for liver cancer.
AuthorsMinmin Sun, Jinchun Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng
JournalOncology reports (Oncol Rep) Vol. 19 Issue 1 Pg. 177-85 (Jan 2008) ISSN: 1021-335X [Print] Greece
PMID18097593 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Immunoglobulins
  • RNA, Messenger
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • SP1 antigen
  • Adenosine
Topics
  • Adenosine (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Base Sequence
  • Blotting, Western
  • Carcinoma, Hepatocellular (metabolism)
  • Cell Line, Tumor
  • Electrophoretic Mobility Shift Assay
  • Humans
  • Immunoglobulins (drug effects, metabolism)
  • Immunoprecipitation
  • Liver Neoplasms (metabolism)
  • Molecular Sequence Data
  • Promoter Regions, Genetic (drug effects)
  • Protein Biosynthesis (drug effects)
  • RNA, Messenger (analysis)
  • Receptors, TNF-Related Apoptosis-Inducing Ligand (biosynthesis, drug effects, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription, Genetic (drug effects)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: